776
Views
50
CrossRef citations to date
0
Altmetric
Original Articles

Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence

, , , , , , , , , & show all

References

  • Portman DJ, Gass MLS on behalf of the Vulvovaginal Atrophy Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Climacteric 2014;17:557–63
  • Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
  • Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013;20:888–902
  • Ettinger B, Hait H, Reape KZ, Shu H. Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach. Menopause 2008;15:885–9
  • Parish SJ, Nappi RE, Krychman ML, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health 2013; 5:437–47
  • Oge T, Hassa H, Aydin Y, Yalcin OT, Colak E. The relationship between urogenital symptoms and climacteric complaints. Climacteric 2013;16:646–52
  • Santen RJ, Allred DC, Ardoin SP, et al. Executive summary: Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010;95(Suppl 1):s1–66
  • The 2012 hormone therapy position statement of the North American Menopause Society. Menopause 2012;19:257–71
  • de Villiers TJ, Gass MLS, Haines CJ, et al. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric 2013;16:203–4
  • de Villiers TJ, Pines A, Panay N, et al., on behalf of the International Menopause Society. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013;16:316–37
  • Kaufmann R, Hibst R. Pulsed Erbium:YAG laser ablation in cutaneous surgery. Lasers Surg Med 1996;19:324–30
  • Reynolds N, Cawrse N, Burge T, Kenealy J. Debridement of a mixed partial and full thickness burn with an erbium:YAG laser. Burns 2003;29:183–8
  • Baraldi CE, Puricelli E, Kulkes S, Martins GL. Er:YAG laser in oral soft tissue surgery. J Oral Laser Applications 2001;1:24
  • Levy JL, Trelles MA. New operative technique for treatment of xanthelasma palpebrarum: laser inverted resurfacing: preliminary report. Ann Plast Surg 2003;50:339–43
  • Vizintin Z, Rivera M, Fistonić I, et al. Novel minimally invasive VSP Er:YAG laser treatments in gynecology. J LAHA 2012;1:46–58.
  • Gambacciani M, Levancini M. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause. Minerva Ginecol 2015;67:1–2
  • Gambacciani M, Levancini M. Vaginal erbium laser: the second generation thermotherapy for the genitourinary syndrome of menopause (GSM) in breast cancer survivors. A preliminary report of a pilot study. It J Gynaecol Obstet 2015;27:N.1
  • Gaspar A. Comparison of new minimally invasive Er:YAG laser treatment and hormonal replacement therapy in the treatment of vaginal atrophy. Climacteric 2014;17(Suppl 1):48–108, p. 124
  • Fistonic I. Erbium laser treatment for early stages of stress urinary incontinence (SUI) in women. Presented at the 38th Annual Meeting of the International Urogynecological Association, May 2013, Dublin
  • Fistonic I. Erbium laser treatment for early stages of stress urinary incontinence (SUI) and vaginal relaxation significantly improves pelvic floor function. Presented at the 15th Congress of Human Reproduction, March 2013, Venice
  • Lee MS. Treatment of vaginal relaxation syndrome with an erbium: YAG laser using 90° and 360° scanning scopes: a pilot study & short-term results. Laser Ther 2014;23:129–38
  • Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric 2015;18:757–63
  • Salvatore S, Nappi RE, Zerbinati N, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 2014;17:363–9
  • Salvatore S, Nappi RE, Parma M, et al. Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy. Climacteric 2015;18:219–25
  • Salvatore S. Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study. Menopause 2015;22:845–9
  • Zerbinati N, Serati M, Origoni M, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Laser Med Sci 2015;30:429–36
  • Perino A, Calligaro A, Forlani F, et al. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas 2015;80:296–301
  • Rosen RC, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191–208
  • Filocamo MT, Serati M, Li Marzi V, et al. The Female Sexual Function Index (FSFI): linguistic validation of the Italian version. J Sex Med 2014;11:447–53
  • Nappi RE, Albani F, Vaccaro P, et al. Use of the Italian translation of the sexual function index (FSFI) in routine gynecological practice. Gynecol Endocrinol 2008;24:214–9
  • Bachmann GA, Notelovitz M, Kelly SJ, et al. Long-term nonhormonal treatment of vaginal dryness. Clin Pract Sexuality 1992;8:3–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.